Centrexion Therapeutics is a late clinical-stage biopharmaceutical company focused on becoming a leader in identifying, developing and commercializing novel, non-opioid and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain.

Biotechnology

Education

Pharmaceutical

Centrexion Therapeutics

Jeffrey B. Kindler

Ryan Shultz

Amy Conley

James Connolly

Pamela Gifford - Isaacson

Lynne Sole

Colleen Newman

James N. Campbell

Mike Ward

Jonathan Walker

Jonathan Guerriero

Randall Stevens

The Leadership Team at Centrexion Therapeutics plays a critical role in guiding the company's strategic direction and operational execution. Comprising key executives such as the CEO, Chief Scientific Officer, and Chief Medical Officer, this team closely collaborates to advance the development of innovative, non-opioid therapies for chronic pain, ensuring alignment across research, clinical development, manufacturing, and financial operations to meet the company's goals.

Leadership Team

Clinical Operations and Development

Leadership Team

About

Team members

Other teams at Centrexion Therapeutics

Clinical Operations and Development